VOYA Investment Management’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.7K Buy
21,011
+7,321
+53% +$31.1K ﹤0.01% 2247
2025
Q4
$49.4K Hold
13,690
﹤0.01% 2343
2025
Q3
$51.6K Sell
13,690
-7,148
-34% -$27.6K ﹤0.01% 2382
2025
Q2
$80.6K Buy
20,838
+1,871
+10% +$10.1K ﹤0.01% 2531
2025
Q1
$94.8K Sell
18,967
-2,275
-11% -$14.4K ﹤0.01% 2441
2024
Q4
$153K Sell
21,242
-2,108
-9% -$16.1K ﹤0.01% 2470
2024
Q3
$143K Sell
23,350
-100,789
-81% -$683K ﹤0.01% 2570
2024
Q2
$826K Sell
124,139
-164,134
-57% -$1.21M ﹤0.01% 1729
2024
Q1
$2.93M Buy
288,273
+267,769
+1,306% +$2.72M ﹤0.01% 1196
2023
Q4
$231K Buy
20,504
+875
+4% +$3.65K ﹤0.01% 2507
2023
Q3
$51K Hold
19,629
﹤0.01% 2853
2023
Q2
$69.3K Buy
+19,629
New +$88.1K ﹤0.01% 2873
2022
Q2
Sell
-14,510
Closed -$88K 2768
2022
Q1
$88K Hold
14,510
﹤0.01% 2528
2021
Q4
$133K Sell
14,510
-66,843
-82% -$710K ﹤0.01% 2617
2021
Q3
$920K Buy
81,353
+68,560
+536% +$834K ﹤0.01% 1624
2021
Q2
$126K Buy
+12,793
New +$175K ﹤0.01% 2728

Other funds holding ALT

VOYA Investment Management's ALT Position: Q1 2026 in Review

VOYA Investment Management increased its Altimmune (ALT) stake by 53% in Q1 2026, buying an estimated $31.1K and bringing the position to 21,011 shares worth $64.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2247.

VOYA Investment Management first reported a position in ALT in Q2 2021 and has held it in 16 quarters since. The position peaked at $2.93M in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • VOYA Investment Management held 21,011 shares of Altimmune worth $64.7K as of Q1 2026.
  • VOYA Investment Management bought 7,321 Altimmune shares in Q1 2026, an estimated $31.1K.
  • Altimmune made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2247 holding.
  • VOYA Investment Management first reported a position in Altimmune in Q2 2021 and has held it in 16 quarters since.
  • VOYA Investment Management's Altimmune position peaked at $2.93M in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.